comparemela.com
  1. Home
  2. Live Updates
  3. Inversago Pharma Inc.: Inversago Pharma startet klinische Phase-1-Studie zu INV-202, einem peripher wirkenden CB1-Blocker der nächsten Generation : comparemela.com

Inversago Pharma Inc.: Inversago Pharma startet klinische Phase-1-Studie zu INV-202, einem peripher wirkenden CB1-Blocker der nächsten Generation

Inversago Pharma Inc.: Inversago Pharma startet klinische Phase-1-Studie zu INV-202, einem peripher wirkenden CB1-Blocker der nächsten Generation

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

,Biotechnology Companies ,Development New Therapies ,Active Ingredient ,Metabolic Diseases ,Kidney Disease ,New Class ,Metabolic Diseases New Treatment Options ,Adipose Tissue ,More Mechanism ,Provision New Treatment Options ,Quality Of Life ,Further Information ,Original Text ,Language Version ,Same They ,Original Version ,Free Securities Trading ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.